• Actinium Pharmaceuticals granted a newly hired non-executive employee a non-qualified stock option to purchase 3,000 shares on Oct. 26, 2026.
• The option has an exercise price of $1.40 per share and a 10-year term.
• Initially, 28% of the underlying shares vest on the grant date’s first anniversary.
• The remainder vest in equal monthly installments of 2% of the underlying shares over the following 36 months.
• Vesting is subject to the employee’s continued service through each applicable vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actinium Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610301715PR_NEWS_USPR_____NY84877) on October 30, 2026, and is solely responsible for the information contained therein.